biote Corp. (BTMD) Investor Relations Documents

biote Corp. (BTMD) investor relations documents from the company's IR site: 1 presentation, 16 press releases; latest deck 2026-04-03. Read in-app with summaries. First-party data.

Investor Presentation: Biote Holdings, LLC is a hormone optimization and therapeutic wellness company that reported $192.2 million in 2025 revenue and $53.5 million in Adjusted EBITDA.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-05Press releaseBiote Reports Second Quarter 2026 Financial Results
2026-07-22Press releaseBiote Schedules Second Quarter 2026 Financial Results Release and Conference Call
2026-06-01Press releaseBiote Appoints Komal Bajaj, MD, MS as Chief Medical Officer
2026-05-06Press releaseBiote Reports First Quarter 2026 Financial Results
2026-04-22Press releaseBiote Schedules First Quarter 2026 Financial Results Release and Conference Call
2026-04-03PresentationInvestor Presentation
2026-03-11Press releaseBiote Reports Fourth Quarter and Full Year 2025 Financial Results
2026-02-25Press releaseBiote Schedules Fourth Quarter and Full Year 2025 Financial Results Release and Conference Call
Press releaseBiote Schedules Third Quarter 2025 Financial Results Release and Conference Call
Press releaseEarnings Release
Press releaseNews Release
2024-02-27Press releasePDF Version
2022-05-11Press releaseBiote Reports First Quarter 2022 Financial Results and Provides Corporate Update
Press releaseSTUDY: TESTOSTERONE PELLET THERAPY REDUCES BREAST CANCER INCIDENCE IN WOMEN
Press releaseNearly 40% of Women Say They were Misdiagnosed During Perimenopause, National Survey Reveals
Press releaseLARGEST REAL-WORLD STUDY OF BIOABSORBABLE TESTOSTERONE PELLETS IN MEN AND WOMEN SHOWS LOW COMPLICATION RATES OVER 7 YEAR
Press releaseBIOTE ANNOUNCES PARTICIPATION IN ICR CONFERENCE 2022

BTMD overview · BTMD earnings · BTMD financials · BTMD KPIs · BTMD ownership · BTMD peers · BTMD filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.